‘Are bacteria making #RSV infections worse in kids? Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, ...

Viroksavir is under clinical development by Traws Pharma and currently in Phase I for Haemophilus influenzae Type A Infections. According to GlobalData, Phase I drugs for Haemophilus influenzae Type A ...

Despite the success of Haemophilus influenzae type b vaccines ... At least half of invasive H influenzae infections are caused by nontypable strains. The spectrum of diseases includes sinusitis ...

Viroksavir is under clinical development by Traws Pharma and currently in Phase I for Haemophilus influenzae Type B Infections. According to GlobalData, Phase I drugs for Haemophilus influenzae Type B ...

A new scoping review examines the impact of respiratory bacteria on the severity of respiratory syncytial virus (RSV) ...

Guillain-Barré Syndrome is an uncommon, rare neurological condition in which the immune system mistakenly attacks the body's ...

The following is a summary of “NTHi killing activity is reduced in COPD patients and is associated with a differential ...

At first, much the same. But inevitably, dangerous diseases would resurge in a country that isn’t prepared for them.

In terms of its effectiveness in preventing deaths, our analysis of the data shows that influenza vaccination is able to ...

The nasal microbiota acts as a first line of defence. When this balance is disrupted, it can pave the way for inflammation ...

Haemophilus parasuis is a significant bacterial ... Recent research has focused on understanding the mechanisms of H. parasuis infections, the host's immune response, and the development of ...